Health Care Journals | Open Access - Edelweiss | Edelweiss Publications

Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Antibody therapy

Antibody therapy: Antibodies are a key component of the adaptive immune response, playing a central role in both recognizing foreign antigens and stimulating immune response. Antibodies are Y-shaped proteins produced by some B cells and are composed of two regions: an antigen-binding fragment (Fab), which binds to antigens, and a Fragment crystallizable (Fc) region, which interacts with so-called Fc receptors that are expressed on the surface of different immune cell types including macrophages, neutrophils and NK cells. Many immunotherapeutic regimens involve antibodies. Monoclonal antibody technology engineers and generates antibodies against specific antigens, such as those present on tumor surfaces. These antibodies that are specific to the antigens of the tumor, can then be injected into a tumor

Two types are used in cancer treatments naked monoclonal antibodies and Conjugated monoclonal antibodies are joined to another molecule

Edelweiss: Cancer Open Access is an open access journal which aims to publish most complete and genuine source of information in the form of short commentary, mini review, case report, related, but not limited to above areas and making them available freely through online without any subscriptions and restrictions to researches worldwide

Editorial Board

Jhon Smith

Professor

editor
Jhon Smith

Professor

editor
Jhon Smith

Assistant Professor

editor
Jhon Smith

Professor

editor